Format

Send to

Choose Destination
Cancer. 1992 Oct 1;70(7):1951-5.

Prognostic value of breast cancer aromatase.

Author information

1
Department of Medicine, Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033.

Abstract

The estrogen receptor, progesterone receptor, and intratumoral aromatase content of 127 breast carcinomas were determined. Patients whose tumor contained either estrogen or progesterone receptors had a longer disease-free interval, but no difference in survival was observed. Measurable aromatase activity was detected in 78 of 113 (69%) tumors. There was no relationship between aromatase activity and disease-free interval or survival.

Supplemental Content

Loading ...
Support Center